Inventor
ZHANG GEOFF G Z
US39 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG GEOFF G Z”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
12 patentsUS9539250B2Jan 10, 2017
Salt and crystalline forms thereof of a drug
ABBVIE INC3 citations84
US8969569B2Mar 3, 2015
Salt and crystalline forms thereof of a drug
ABBVIE INC5 citations84
US8987453B2Mar 24, 2015
Azaadamantane derivatives and methods of use
ABBVIE INC6 citations83
US10329276B2Jun 25, 2019
Salt and crystalline forms thereof of a drug
ABBVIE INC1 citations73
US9873681B2Jan 23, 2018
Salt and crystalline forms thereof of a drug
ABBVIE INC1 citations62
US9139536B2Sep 22, 2015
Anti-infective agents and uses thereof
ABBVIE INC2 citations62
US8362014B2Jan 29, 2013
ABT-263 crystalline forms
ABBVIE INC2 citations61
US8362013B2Jan 29, 2013
Salt of ABT-263 and solid-state forms thereof
ABBVIE INC2 citations56
US8592589B2Nov 26, 2013
Methods of treating cancer with a thieno[3,2-C]pyridine
ABBVIE INC0 citations51
US8357804B2Jan 22, 2013
Crystal forms of kinase inhibitors
ABBVIE INC0 citations51
US8927723B2Jan 6, 2015
Preparation of pyridonecarboxylic acid antibacterials
ABBVIE INC0 citations50
US8648196B2Feb 11, 2014
Preparation of pyridonecarboxylic acid antibacterials
ABBVIE INC0 citations50
ABBOTT LAB
9 patentsUS7728143B2Jun 1, 2010
Salt and crystalline forms thereof of a drug
ABBOTT LAB13 citations92
US7259186B2Aug 21, 2007
Salts of fenofibric acid and pharmaceutical formulations thereof
ABBOTT LAB22 citations90
US7576216B2Aug 18, 2009
Preparation of pyridonecarboxylic acid antibacterials
ABBOTT LAB4 citations71
US7354937B2Apr 8, 2008
(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
ABBOTT LAB6 citations71
US7351833B2Apr 1, 2008
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
ABBOTT LAB4 citations70
US7538226B2May 26, 2009
(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
ABBOTT LAB4 citations59
US7449584B2Nov 11, 2008
N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1
ABBOTT LAB0 citations47
US7446206B2Nov 4, 2008
N-((2Z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2
ABBOTT LAB0 citations47
US7902371B2Mar 8, 2011
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
ABBOTT LAB0 citations46
ZHANG GEOFF G Z
7 patentsUS8273892B2Sep 25, 2012
Salt and crystalline forms thereof of a drug
ZHANG GEOFF G Z9 citations92
US8252813B2Aug 28, 2012
Salt and crystalline forms thereof of a drug
ZHANG GEOFF G Z10 citations92
US9051301B2Jun 9, 2015
Crystalline form of a drug
ZHANG GEOFF G Z9 citations84
US8648093B2Feb 11, 2014
Salt and crystalline forms thereof of a drug
ZHANG GEOFF G Z7 citations83
US8513243B2Aug 20, 2013
ABT-263 crystalline forms
ZHANG GEOFF G Z4 citations60
US8633317B2Jan 21, 2014
Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile
ZHANG GEOFF G Z0 citations51
US8633217B2Jan 21, 2014
Crystal forms of kinase inhibitors
ZHANG GEOFF G Z0 citations46